InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Kumar Rashmi, 董事. Director active across 1 company, notably Myriad Genetics INC. Cumulatively, 6 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €189k. Activity tracked since 3 June 2021. The latest transaction was filed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kumar Rashmi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
49,796 股0Common StockSEC:0001628280-25-029972:0
7,500 股@ US$28.01100.0% 占其流量Common StockSEC:0001824720-24-000003:0
15,695 股0Common StockSEC:0001628280-24-027332:0
15,151 股0Common StockSEC:0001824720-23-000002:0
17,275 股0Common StockSEC:0001628280-22-016224:0
12,848 股0Common StockSEC:0001824720-21-000002:0
6 条申报中的 6 条
About Kumar Rashmi
Rashmi Kumar is a Board Member at Myriad Genetics Inc. She is involved in overseeing the company's operations and formulating strategies aimed at enhancing performance. Her expertise in the healthcare sector is beneficial for the organization.
